There are no exercise restrictions for people with mitral valve prolapse. However, they should avoid the same unhealthy lifestyle practices that apply to everyone, including eating non-nutritious food ...

The mitral valve allows blood to flow from the left atrium of the heart into the left ventricle. Mitral regurgitation occurs when the mitral valve leaks blood back into the left atrium. A person’s ...

Hypertrophic cardiomyopathy (HCM) is a primary disease of cardiac muscle characterized by a thickening of the left ventricular wall and often predominantly affecting the interventricular septum. This ...

Vibhu Parcha, M.D., a clinical research fellow in the UAB Division of Cardiovascular Disease, says this study was an extensive surveillance exercise at a national level to look into the implications ...

Minimal forward mitral-valve area was calculated from the hydraulic formulas of Gorlin and Gorlin. 9 The roentgenograms were evaluated by the roentgenologist, and mitral regurgitation was graded ...

The sudden passing of Eleanor Carol Barr, the 39-year-old wife of U.S. Rep. Andy Barr of Kentucky, is putting the spotlight on mitral valve prolapse, or floppy valve syndrome, listed as the cause of ...

The US Food and Drug Administration (FDA) has granted approval for Abbott's Tendyne transcatheter mitral valve replacement (TMVR) system for individuals with mitral valve disease. This device claims ...

SALT LAKE CITY--(BUSINESS WIRE)--Foldax®, Inc. today announced the successful first-in-human use of its biopolymer Tria™ heart valve in surgically replacing a diseased mitral valve. The first case was ...

Greg Denning has never really liked going to the doctor, and for most of his life he's been an active person who was able to avoid significant medical care. That started to change one day when he and ...

InnovHeart may not have grown three sizes in one day, but it’s gotten quite a boost from the recent close of its series C funding round. The Milan-based company makes transcatheter mitral valve ...

SALT LAKE CITY--(BUSINESS WIRE)--Foldax®, Inc., a leader in the development of innovative, polymer heart valves, today announced positive 30-day results from a prospective, multicenter, single-arm, ...